Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome (Q41199354)

28 September 2017

Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome (English)

1 reference

28 September 2017

Guillain–Barré syndrome

0 references

1 reference

Campylobacter jejuni

1 reference

9

Pieter A van Doorn

1 reference

28 September 2017

11

Bart C Jacobs

1 reference

28 September 2017

Ruth Huizinga

1

1 reference

28 September 2017

Bianca van den Berg

2

1 reference

28 September 2017

Wouter van Rijs

3

1 reference

28 September 2017

Anne P Tio-Gillen

4

1 reference

28 September 2017

Willem Jan R Fokkink

5

1 reference

28 September 2017

Liesbeth E Bakker-Jonges

6

1 reference

28 September 2017

Karin Geleijns

7

1 reference

28 September 2017

Janneke N Samsom

8

1 reference

28 September 2017

Jon D Laman

10

1 reference

28 September 2017

27 May 2015

1 reference

28 September 2017

1 reference

28 September 2017

78

1 reference

28 September 2017

3

1 reference

28 September 2017

343-354

1 reference

Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.

28 September 2017

1 reference

Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study

21 January 2018

1 reference

Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni

21 January 2018

1 reference

Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.

21 January 2018

1 reference

Regulation of adaptive immunity by the innate immune system

21 January 2018

1 reference

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation

21 January 2018

1 reference

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome

21 January 2018

1 reference

Common genetic variants modulate pathogen-sensing responses in human dendritic cells

21 January 2018

1 reference

Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression

21 January 2018

1 reference

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients

21 January 2018

1 reference

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

21 January 2018

1 reference

Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study

21 January 2018

1 reference

Controlled trial prednisolone in acute polyneuropathy

21 January 2018

1 reference

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

21 January 2018

1 reference

Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes

21 January 2018

1 reference

Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.

21 January 2018

1 reference

21 January 2018

1 reference

Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation

21 January 2018

1 reference

Response of Toll-like receptors in experimental Guillain-Barré syndrome: a kinetic analysis.

21 January 2018

1 reference

Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood.

21 January 2018

1 reference

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

21 January 2018

1 reference

Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

A prescription for human immunology

21 January 2018

1 reference

TLR2 utilization of Borrelia does not induce p38- and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells.

21 January 2018

1 reference

LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia

21 January 2018

1 reference

Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae

21 January 2018

1 reference

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

21 January 2018

1 reference

Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity

21 January 2018

1 reference

CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells

21 January 2018

1 reference

Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo

21 January 2018

1 reference

Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity

21 January 2018

1 reference

The recurrent Guillain-Barré syndrome: a long-term population-based study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24442

1 reference

28 September 2017

1 reference